Searching for your content…
In-Language News
Contact Us
888-776-0942
from 8 AM – 10 PM ET
News provided by
Apr 26, 2022, 05:45 ET
Share this article
DUBLIN, April 26, 2022 /PRNewswire/ — The "Hemodialysis Powder Solution Market 2021-2027" report has been added to ResearchAndMarkets.com’s offering.

The global hemodialysis powder solution market is anticipated to grow at a considerable CAGR during the forecast period. The rising prevalence of chronic kidney disease and cardiovascular disorders that leads to renal failure and the requirement for hemodialysis treatment is driving the global hemodialysis powder solution market.
The increasing interference of private organization to increase awareness of such treatments is further anticipated to drive the market growth. In October 2020, The Fresenius Medical Care North America (FMCNA) and Livongo Health, Inc. formed an innovative partnership to improve the lives and outcomes of people with late-stage chronic kidney disease (CKD).

The global hemodialysis powder solution market is segmented based on type and end-user. Based on type, the hemodialysis powder solution market is segmented into hemodialysis concentrates and hemodialysis dry powder. Based on end-user, the hemodialysis powder solution market is segmented into private clinic, public hospital, personal care, nursing home, and others.

Geographically, the global hemodialysis powder solution market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global hemodialysis powder solution market include Baxter International Inc., Rockwell Medical, Inc, O.M.A.R S.r.l Pharmaceutical Blister Solution, and WEGO Health Co., Ltd. among others.

Market Segmentation
The Report Covers
Key Topics Covered:

1. Report Summary

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion

3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities

4. Market Segmentation
4.1. Global Hemodialysis Powder Solution Market by Type
4.1.1. Hemodialysis Concentrates
4.1.2. Hemodialysis Dry Powder
4.2. Global Hemodialysis Powder Solution Market by End-User
4.2.1. Private Clinics
4.2.2. Public Hospitals
4.2.3. Personal Care
4.2.4. Nursing Home
4.2.5. Other

5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles
6.1. Baxter International Inc.
6.2. Farmasol
6.3. O.M.A.R S.r.l Pharmaceutical Blister Solution
6.4. Renacon Pharma Ltd.
6.5. Rockwell Medical, Inc.
6.6. WEGO Health Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/budr4u
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Cision Distribution 888-776-0942
from 8 AM – 9 PM ET

source